GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:22003382
Citation |
Borovjagin, AV, Dong, J, Passineau, MJ, Ren, C, Lamani, E, Mamaeva, OA, Wu, H, Keyser, E, Murakami, M, Chen, S and MacDougall, M (2011) Adenovirus gene transfer to amelogenesis imperfecta ameloblast-like cells. PLoS ONE 6:e24281 |
---|---|
Abstract |
To explore gene therapy strategies for amelogenesis imperfecta (AI), a human ameloblast-like cell population was established from third molars of an AI-affected patient. These cells were characterized by expression of cytokeratin 14, major enamel proteins and alkaline phosphatase staining. Suboptimal transduction of the ameloblast-like cells by an adenovirus type 5 (Ad5) vector was consistent with lower levels of the coxsackie-and-adenovirus receptor (CAR) on those cells relative to CAR-positive A549 cells. To overcome CAR -deficiency, we evaluated capsid-modified Ad5 vectors with various genetic capsid modifications including "pK7" and/or "RGD" motif-containing short peptides incorporated in the capsid protein fiber as well as fiber chimera with the Ad serotype 3 (Ad3) fiber "knob" domain. All fiber modifications provided an augmented transduction of AI-ameloblasts, revealed following vector dose normalization in A549 cells with a superior effect (up to 404-fold) of pK7/RGD double modification. This robust infectivity enhancement occurred through vector binding to both α(v)β3/α(v)β5 integrins and heparan sulfate proteoglycans (HSPGs) highly expressed by AI-ameloblasts as revealed by gene transfer blocking experiments. This work thus not only pioneers establishment of human AI ameloblast-like cell population as a model for in vitro studies but also reveals an optimal infectivity-enhancement strategy for a potential Ad5 vector-mediated gene therapy for AI. |
Links |
PubMed PMC3189176 Online version:10.1371/journal.pone.0024281 |
Keywords |
Adenoviridae/genetics; Adenoviridae/physiology; Adolescent; Ameloblasts/metabolism; Amelogenesis Imperfecta/pathology; Capsid/metabolism; Cell Line, Tumor; Coxsackie and Adenovirus Receptor-Like Membrane Protein; Genetic Vectors/genetics; Humans; Receptors, Virus/genetics; Transduction, Genetic/methods; Viral Tropism |
edit table |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
GO:0005737: cytoplasm |
ECO:0000314: |
C |
Figure 2E shows CAR expression in cytoplasm (white arrows) in two different cell types |
complete | ||||
GO:0005923: tight junction |
ECO:0000314: |
C |
Figure 2E shows CAR protein is expressed at tight junctions (Red Arrows) in specific cell type |
complete | ||||
part_of |
GO:0005737: cytoplasm |
ECO:0000314: direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
part_of |
GO:0005923: bicellular tight junction |
ECO:0000314: direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
See also
References
See Help:References for how to manage references in GONUTS.